Alembic Pharma gets final approval from USFDA for OCD treatment drug

The company has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Clomipramine Hydrochloride Capsules USP in the strengths 25 mg, 50 mg, and 75 mg, Alembic Pharmaceuticals said in a regulatory filing.

Related Keywords

,Anafranil Capsules Of Spec ,Drug Administration ,Clomipramine Hydrochloride ,Obsessive Compulsive Disorder ,Clomipramine Hydrochloride Capsules ,Anafranil Capsules ,Hydrochloride Capsules ,Us Food And Drug Administration ,Ocd ,Susa ,Usfda ,Alembic ,Alembic Pharmaceuticals ,Us ,வெறித்தனமான கட்டாய கோளாறு ,ஓக்ட் ,அமெரிக்கா ,அலெம்பிக் ,அலெம்பிக் மருந்துகள் ,எங்களுக்கு ,